Mereo BioPharma Group Plc (MREO)
0.3922
-0.01
(-1.38%)
USD |
NASDAQ |
Feb 25, 15:20
Mereo BioPharma Group Cash from Financing (TTM) : 0.0608M for Sept. 30, 2025
Cash from Financing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | 12.98M |
| NuCana Plc | 36.12M |
| Autolus Therapeutics Plc | 27.46M |
| Bicycle Therapeutics Plc | -2.030M |
| AstraZeneca PLC | -7.562B |